Double-blind, single-dose escalation study of PTC-299 in Healthy volunteers

Trial Profile

Double-blind, single-dose escalation study of PTC-299 in Healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs PTC 299 (Primary)
  • Indications Breast cancer; CNS cancer; Neurofibromatoses; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors PTC Therapeutics
  • Most Recent Events

    • 01 Jul 2016 Results published in the Clinical Pharmacology in Drug Development
    • 04 Dec 2006 Checked against 1054820.
    • 21 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top